Dawn of the Planet of the TLOGlodytes!
by DrKSSMDPhD | December 8, 2014 4:15 pm
DR. KSS LOOKS AT A COMPANY TACKLING HEPATITIS B
This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.
Source URL: https://www.stockgumshoe.com/2014/12/microblog-dawn-of-the-planet-of-the-tloglodytes/
Big blow or big bust to stem cells research. Japanese Giving up on STAP cells. The researcher Ms. Obokata “remain very puzzled by these results”. Her advisor Mr. Sasai committed suicide for the scandal in August.
http://news.sciencemag.org/asiapacific/2014/12/riken-team-gives-stap-cells
Please excuse the personal nature of the post. Scroll on to avoid.
Referencing the good doctor’s comment about Ascendis and valid medical uses for human growth hormone: I have been on and off and now back on hGH as a kind of egg-white binder blender for hormone replacement therapy benefit. Are there other gummies in the same endocrine boat? Lacking a pituitary to function as a chemical CPU mandates daily intake of the hormones necessary for our systems to function. They are a vital part of our army against entropy. Early on, my doctors suggested hGH could help smooth things out for me. I tried and it worked, but the negative connotations of its use got me to stop for about a year. That year did not go as well so I began again. There have been no musculature changes and I am still a very non- aggressive type, but am I deluding myself somehow? Any endocrine specialists who can weigh in would be appreciated.
Jim, I didn’t mean to count you out in what I said. You have a definitive need for GH. My main thrust was that people in your situation, now sans pituitary are rare and thus I don’t know how Ascendis arrives at a $3B market for it. In your case it is necessary for life and health and should not cause bony overgrowth or neuropsychiatric effects. Throughout the US are many “aging guru” MD’s with offices in shopping mall storefronts who rationalize giving GH on the flimsiest of premises, for muscle gain, for “turning back the clock,” and especially for weight loss. Many celebs pay out of pocket for it as insurance is loath to cover it except in situations like yours. Because you are genuinely deficient you need it and should get no downside from it, and such downsides in inappropriate use cases include DM-II. One case series has suggested that those taking it supraphysiologically are more CAD prone. In your case, Ascendis’s product would turn it into a weekly SQ injection for you. I suggest you not stop it. Tough to picture you going all Incredible Hulk on anyone.
As always, thank you from the Hulk Not To Be. I remember seeing Lyle Alzado near his end, and the devastating toll hGH took on his physical and mental frame. A sobering example that should be required study for all college athletes.
Interestingly (and unfortunately), I cannot get the copay assistance from Novo Nordisk once I start to use Medicare – and Medicare doesn’t cover hGH for people like me – so the cost will prohibitive. Another reason (other than I still love it) to keep teaching. I will fight the powers that be when I must. Peace for the season to all …
Jim….perhaps you already know, but quite a few companies make hGH (http://www.hgfound.org/res_rGHmanufacturers.asp). I think that, as long as it is not bank-breaking, it is really best to be on it. I would solicit charitable release of it from whomever you can.
I imagine I will find a way … usually do. Thanks again.
$JUNO: irregulars should probably wait to get in. These things always cool off. BLCM is already -10%
$JUNO, got filled at $36.98 against my better judgment!
IMGN-Dr. KSS. – Do you think that this equity is a buy at 6.22? Best-Ben
No, definitely not. $IMGN’s had this coming for a long time. It’s a company premised on a straw man….that chemical linkages between antibodies and drugs in conjugates are too weak and need snugging. They’ve snugged things so well that the conjugates don’t work. Be careful what you wish for, and don’t wish for IMGN shares in your portfolio.
IMGN- Dr. KSS.I wouldn’t touch ’em captain 😉 THANK YOU! Have a great weekend ALL!
A ding for $ABBV? Strong up move on $GILD, with heavy volume. Is word already leaking?
I wonder why the big move today in $AKAO, other than, of course, the fact that I took profits at $12.60 when I thought it was too technically frothy. I just hope it isn’t acquired before I find my re-entry. Along with $CTIX, Archaogen is my top pick now that $DRTX is in the bank. Obviously a believer in the necessity for an antibiotic future. So why did I sell?
Wo is to say it wont crash tomorrow?. Every stock will rise/fall from where you bought/sold. Its a 50/50 at best. But YOU got the money in the bank which is 100% safety. Dont beat yourself up about both the winners and the losers. Be happy you made a profit rather than a loss. You can always buy back.
Jim, it rocks and rolls on minimal volume because so few shares are actually available for trading.
$JUNO is down from its highs in after market trading to $34.50 but still more time to go.
It seems that only some of the Schwab customers were able to get some shares in the IPO. From comments here, TDAmerirade, although allocated part of the offering, did not seem to award any shares to the Gummies here.
Kenny, Schwab has an arrangement with Goldman Sachs and Morgan Stanley such that they get an allotment whenever GS and MS are underwriters of an IPO. Re. CERS, my $.02;
it is overbought when you look at Relative Strength. Whenever RS is > 70, it is considered
overbought and CERS RS is currently sitting @ 84.40 on a daily chart. So it would appear
it might “cool down” somewhat. But that and $5 will get you a cup of coffee @ Starbucks.
I don’t own nor have I ever been a CERS “owner”.
Frank
Re: Post 348
Just remember that stocks can remain in overbought and oversold territory for a very long time. Like all indicators/oscillators, RS is simply a tool, not a crystal ball.
Franklin re $JUNO: TDA claims they offer all GS offerings and they did participate in JUNO as they took indications from me and other gummies. But when the all was done, they didn’t come through at all.
Perhaps I should split my account and open up one with Schwab as well. But I hate having too many accounts.
I was never able to figure out how TDA allocate the IPO. Their process is so opaque and inefficient, I never know when I would get shares. They did give me 200 LC, which actually had a better 1st day performance than JUNO.
We just posted Dr. KSS’s newest article: http://www.stockgumshoe.com/2014/12/the-finale-is-grand-the-gain-from-pain-mainly-explained/
Donuts and eggnog over at
http://www.stockgumshoe.com/2014/12/the-finale-is-grand-the-gain-from-pain-mainly-explained/?utm_source=121914ff&utm_campaign=FridayFile&utm_medium=email
More about CERS :
Scottrade’s company background:
“Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on the Company’s technology for controlling biological replication, is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. The Company has worldwide rights for its intercepts Blood System for three blood components: platelets, plasma and red blood cells. The INTERCEPT Blood System for platelets, or platelet system, and the INTERCEPT Blood System for plasma, or plasma system, have received Conformite Europeene (CE) marks and are being marketed and sold in a number of countries in Europe, The Commonwealth of Independent States, the Middle East and selected countries in other regions worldwide. The Company sells both the platelet and plasma systems using its direct sales force and through distributors. http://www.cerus.com “
NEWS:
“Second U.S. Approval for Cerus’ INTERCEPT Blood System Extends Pathogen Reduction to Platelet Components CONCORD, Calif.—- Cerus Corporation (NASDAQ:CERS) today announced that the U.S. Food and Drug Administration (FDA) has approved the INTERCEPT Blood System for platelets. The INTERCEPT platelet system is approved for ex vivo preparation of pathogen-reduced apheresis platelet components in order to reduce the risk of transfusion-transmitted infection (TTI), including sepsis, and to potentially reduce the risk of transfusion-associated graft versus host disease (TA-GVHD). ” ( Excerpt from http://finance.yahoo.com/news/fda-approves-intercept-blood-system-002000252.html )
–S&P Capital IQ six analysts have a buy rating;
–Thomson Reuters has a strong buy; and
–Market Edge’s Second Opinion has a buy (Rating as of 12/12/14) :
—–“Moving Average Convergence/Divergence (MACD) indicates a Bullish Trend.
—–“Chart pattern indicates a Strong Upward Trend.
—–“Relative Strength is Bullish.
—–“Up/Down volume pattern indicates that the stock is under Accumulation.
—–“The 50 day Moving Average is rising which is Bullish.
—–“The 200 day Moving Average is falling which is Bearish.
—–“Look for Support at 4.32.
—–“Price is above Resistance of 4.75 which is Bullish.”
It passed up through a resistance level of $5.80 (this price was a year ago) (now the main support level?) and is now $0.60 above that. The price range today was $0.40, from a high of $6.80 to a low of $6.40. I’m going to use follow JP’s advice and wait till Monday and see what happens.
Thanks to everybody!
Hi Pockets: Some excellent info there that shows youre getting a good grip on TA. One criticism…….buy/sell reccos are really only relevant if you state the price at which the recco was made…say $5 and its now $10…is it still a buy ?
Thanks HP. I appreciate you digging out all that.
The way this method works is that a substance is added to the blood or blood product (plasma, platelets) that chemically crosslinks all DNA and RNA permanently. Red cells don’t have DNA, and though platelets do, neither RNA or DNA are needed for platelets to aggregate normally. They are basically little suicide bags of granules of chemicals needed for clotting and healing.
Considering getting back in.
$STML, Hi Fellow Gummies!
I might have missed previous conversations on $STML. with the results in 2 weeks i want to reinforce my thoughts about the company. Can someone point me to previous discussions on $STML.
Thanks in advance!